|
Oct 7
|
BioCryst (BCRX) Upgraded to Buy: Here's Why
|
|
Oct 2
|
Enanta Pharmaceuticals (ENTA) Surges 5.6%: Is This an Indication of Further Gains?
|
|
Oct 2
|
BioCryst Begins Enrollment in Phase 1 Trial Evaluating BCX17725, a KLK5 Inhibitor, for the Treatment of Netherton Syndrome
|
|
Oct 1
|
BioCryst Secures Major US Health Department Influenza Drug Deal
|
|
Oct 1
|
BioCryst secures $69m contract from US to supply RAPIVAB for influenza
|
|
Sep 30
|
With 80% institutional ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a favorite amongst the big guns
|
|
Sep 30
|
U.S. Government Awards BioCryst $69 Million RAPIVAB® (peramivir injection) Contract for Strategic National Stockpile
|
|
Sep 6
|
BioCryst Presents New ORLADEYO® (berotralstat) Data at 7th Bradykinin Symposium
|
|
Sep 5
|
BioCryst Appoints Dr. Donald Fong Chief Medical Officer
|
|
Aug 29
|
High Growth Tech Stocks To Watch In August 2024
|
|
Jul 30
|
Zoetis (ZTS) Earnings Expected to Grow: Should You Buy?
|
|
Jul 29
|
Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know
|
|
Jun 26
|
BioCryst Pharmaceuticals Insiders Added US$1.05m Of Stock To Their Holdings
|
|
May 15
|
Insider Buying: Chief R&D Officer Helen Thackray Acquires 30,000 Shares of BioCryst ...
|
|
May 15
|
Director Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX)
|
|
May 15
|
Insider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX)
|
|
May 15
|
Insider Buying: CFO Anthony Doyle Acquires Shares of BioCryst Pharmaceuticals Inc (BCRX)
|
|
May 14
|
BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology
|
|
May 13
|
ORLADEYO® (berotralstat) Approved in Mexico
|
|
May 9
|
BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Utilization Among Patients with HAE Following Initiation of ORLADEYO® (berotralstat)
|